Senior insider sale
SVP, Chief Medical Officer at AURINIA PHARMACEUTICALS INC. — senior position signals high conviction
$54.67M
59.59K shares
What this filing means
KEENAN GREG plans to sell 59.59K shares of AURINIA PHARMACEUTICALS INC. valued at approximately $54.67M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/5/2026ACC: 0001950047-26-005702
Officer· SVP, Chief Medical Officer
Since Feb 2026
59.59K
Shares to sell
$54.67M
Approx. market value
9.59K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Options Under a Registered Plan
Cash
6/5/2026
9.59KTotal acquired9.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/5/2026 | Exercise of Options Under a Registered Plan Cash | 9.59K | — |
| Total | 9.59K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
25K
Market value
$408.4K
6/4/2026
—Completed
Units to sell
25K
Market value
$54.10M
6/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.59K
Market value
$158.5K
6/5/2026
Total
Units
59.59K
Value
$54.67M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/4/2026 | 25K | $408.4K | — | Completed |
6/2/2026 | 25K | $54.10M | — | Completed |
| Planned — Approximate Date | ||||
6/5/2026 | 9.59K | $158.5K | NASDAQ | Planned |
| Total | 59.59K | $54.67M | ||